发明名称 Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
摘要 Inhibitors of HBV replication of formula (I); including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, R1 to R7 have the meaning as defined herein. ;The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
申请公布号 US9567299(B2) 申请公布日期 2017.02.14
申请号 US201415031493 申请日期 2014.10.22
申请人 JANSSEN SCIENCES IRELAND UC 发明人 Vandyck Koen;Haché Geerwin Yvonne Paul;Kesteleyn Bart Rudolf Romanie;Raboisson Pierre Jean-Marie Bernard
分类号 C07D207/18;A61K31/40;C07D207/09;C07D405/12;C07D207/16;C07D211/60;A61K31/445;A61K45/06;C07D211/34 主分类号 C07D207/18
代理机构 代理人
主权项 1. A compound of Formula (I) or a stereoisomer or tautomeric form thereof, wherein:is each of Ra, Rb, Rc, Rd, Re, Rf and Rg are independently selected from the group consisting of hydrogen and methyl; Rh is hydrogen; Ri is hydrogen; R1, R2 and R3 are independently selected from the group consisting of hydrogen, fluoro, chloro, bromo, —CHF2, —CH2F, —CF3, —CN and methyl; R6 is selected from the group consisting of C1-C6alkyl and a 3-7 membered saturated ring optionally containing one or more heteroatoms each independently selected from the group consisting of O, S and N, said C1-C6alkyl and 3-7 membered saturated ring each optionally substituted with one or more substituents selected from the group consisting of fluoro and C1-C3alkyl, wherein said C1-C3alkyl is optionally substituted with one or more substituents selected from the group consisting of fluoro, —CN, and OH; R7 is hydrogen; or a pharmaceutically acceptable salt or a solvate thereof.
地址 Little Island, Co Cork IE